Michał Danecki

Maria Sklodowska-Curie National Research Institute of Oncology, Department of Clinical Oncology, Poland

N/A

Poster(s):

• 1501 - EFFICACY AND TOLERABILITY OF VENETOCLAX PLUS RITUXIMAB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA – REAL-WORLD ANALYSIS OF POLISH ADULT LEUKEMIA STUDY GROUP